Medical Press Release - Medika Life : Keeping you informed

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Sheba Medical Center Selects Two Digital Startups for Integration into Newly Expanded Rehabilitation Ward

Medika Life - November 28, 2023

Israeli Startups Cognishine and Kemtai Will Begin a Pilot Program at Sheba to Provide Physical, Cognitive and Emotional Rehab Support for Injured Soldiers ARC Innovation...

INOVIO Receives $71 Million Contract From U.S. Department of Defense

Medika Life - August 7, 2020

CELLECTRA® 3PSP is designed to deliver INO-4800 directly into the skin, where the vaccine prompts the body's immune system to drive a robust immune response

Telemedicine Market Size Worth $298.9 Billion By 2028 | CAGR: 22.4%: Grand View Research, Inc.

Medika Life - March 9, 2021

The global telemedicine market size is expected to reach USD 298.9 billion by 2028, according to a new report by Grand View Research

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

FINN Partners Brings Aboard the Pharmacy Podcast Network

South University Announces New MSPA Program at West Palm Beach Campus

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Sheba Medical Center Selects Two Digital Startups for Integration into Newly Expanded Rehabilitation Ward

INOVIO Receives $71 Million Contract From U.S. Department of Defense

Telemedicine Market Size Worth $298.9 Billion By 2028 | CAGR: 22.4%: Grand View Research, Inc.

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories